Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2017?

84 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2017. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 27,519,844
Share change: +1,260,514
Total reported value: $726,508,386
Put/Call ratio: 121%
Price per share: $26.40
Number of holders: 84
Value change: +$33,694,307
Number of buys: 49
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Essex Woodlands Management, Inc.	13F	Company	4.4%	4,592,047	$95,515,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	3.3%	3,459,844	$71,965,000	—	31 Mar 2017	13F
FRANKLIN RESOURCES INC	13F	Company	2.9%	2,983,600	$62,059,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2%	2,091,807	$43,510,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	2%	2,048,054	$42,600,000	—	31 Mar 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.8%	1,926,862	$40,079,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	1.7%	1,817,798	$37,810,000	—	31 Mar 2017	13F
Polar Capital LLP	13F	Company	1.2%	1,296,371	$26,960,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	0.83%	868,118	$18,056,000	—	31 Mar 2017	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.56%	582,900	$12,124,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.52%	548,650	$11,412,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.43%	449,853	$9,356,000	—	31 Mar 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.33%	350,000	$7,280,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	0.3%	316,900	$6,592,000	—	31 Mar 2017	13F
PointState Capital LP	13F	Company	0.26%	276,500	$5,751,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.25%	265,937	$5,532,000	—	31 Mar 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.22%	235,000	$4,888,000	—	31 Mar 2017	13F
Rhenman & Partners Asset Management AB	13F	Company	0.2%	210,000	$4,368,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	178,435	$3,711,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.15%	153,670	$3,197,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.12%	122,000	$2,538,000	—	31 Mar 2017	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.09%	98,684	$2,053,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	92,490	$1,924,000	—	31 Mar 2017	13F
SUFFOLK CAPITAL MANAGEMENT LLC	13F	Company	0.08%	83,495	$1,737,000	—	31 Mar 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.08%	81,351	$1,692,000	—	31 Mar 2017	13F
Vivo Capital, LLC	13F	Company	0.07%	77,373	$1,609,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.07%	75,274	$1,566,000	—	31 Mar 2017	13F
Granite Investment Partners, LLC	13F	Company	0.07%	71,241	$1,482,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	71,148	$1,479,000	—	31 Mar 2017	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.05%	56,610	$1,177,000	—	31 Mar 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.05%	54,971	$1,143,000	—	31 Mar 2017	13F
Allianz Asset Management GmbH	13F	Company	0.05%	50,613	$1,053,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	40,270	$838,000	—	31 Mar 2017	13F
PARADIGM ASSET MANAGEMENT CO LLC	13F	Company	0.03%	35,700	$742,560	—	31 Mar 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.03%	35,525	$739,000	—	31 Mar 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	35,338	$735,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.03%	33,698	$701,000	—	31 Mar 2017	13F
Swiss National Bank	13F	Company	0.03%	32,850	$683,000	—	31 Mar 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	27,401	$570,000	—	31 Mar 2017	13F
Nationwide Fund Advisors	13F	Company	0.03%	26,430	$550,000	—	31 Mar 2017	13F
State of New Jersey Common Pension Fund D	13F	Company	0.02%	26,000	$541,000	—	31 Mar 2017	13F
Crestline Management, LP	13F	Company	0.02%	25,000	$520,000	—	31 Mar 2017	13F
ALPS ADVISORS INC	13F	Company	0.02%	24,531	$510,000	—	31 Mar 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	24,000	$499,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	23,301	$485,000	—	31 Mar 2017	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	22,938	$477,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	22,705	$472,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.02%	22,679	$472,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	20,131	$419,000	—	31 Mar 2017	13F
FEDERATED HERMES, INC.	13F	Company	0.02%	20,051	$417,000	—	31 Mar 2017	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2017

As of 30 Jun 2017, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,519,844 shares. The largest 10 holders included Essex Woodlands Health Ventures, Inc., JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, BlackRock Inc., Bank of New York Mellon Corp, ArrowMark Colorado Holdings LLC, WELLINGTON MANAGEMENT GROUP LLP, Polar Capital LLP, VANGUARD GROUP INC, and CANADA PENSION PLAN INVESTMENT BOARD. This page lists 84 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.